GHTC is working to advance new funding and policy solutions to accelerate the development of technologies to fight COVID-19 in low-resource settings and ensure equitable access to these tools. Learn more about our ongoing advocacy work.
Learn moreGHTC has created a new resource tracking the current state of R&D efforts to combat COVID-19. The tracker, which will be updated regularly, includes information on R&D efforts supported by the US government, multilateral institutions, and GHTC member organizations.
ViewACTION is a partnership of 13 locally rooted organizations around the world that advocate for life-saving care for millions of people threatened by preventable diseases. They work as equal partners to bring together efforts across borders to increase investments and build political support for global health.
Learn More
Health technologies have the potential to save millions of lives. New tools are needed to slow the global threat of diseases, including HIV/AIDS, malaria, tuberculosis, and neglected tropical diseases, and tackle many other pressing health needs. For diseases and conditions primarily affecting people in the world’s poorest places, there is little to no commercial market to spur R&D. Strong investment and innovative solutions are needed to catalyze the development of new technologies to bring health and opportunity within reach for all people.
Learn More
GHTC strongly endorses yesterday’s declaration from G20 health ministers elevating the importance of investments in new tools and technologies to fight infectious diseases—work that has provided a strong foundation for combatting the COVID-19 pandemic and can be broadly beneficial in confronting a wide range of other threats.
Learn more
GHTC Director Jamie Bay Nishi was quoted in an article in The New Republic discussing the challenges to come in global distribution of COVID-19 vaccines.
View
As a member of the Global Health Council's (GHC) delegation for the second session of the 73rd World Health Assembly (WHA), GHTC joined GHC in its statement from civil society urging continued investments in R&D to achieve universal health coverage (UHC), advance immunization coverage through the Global Vaccine Action Plan, and close the US$1.3 billion funding gap for tuberculosis R&D.
Learn more
Triangle Global Health Consortium
Virtual
View
In this regular feature on Breakthroughs, we highlight some of the most interesting reads in global health research from the past week.
In this regular feature on Breakthroughs, we highlight some of the most interesting reads in global health research from the past week.
On November 19, GHTC hosted a virtual roundtable with four organizations advancing COVID-19 innovations and 12 staff members from congressional offices. The dialogue focused on the need for COVID-19 innovations designed for use in low-resource settings and the role the US Agency for International Development (USAID) could play in supporting this effort. Read on for a recap of the event.
